The National Office of Animal Health (NOAH) and the International Federation for Animal Health Europe (IFAH) have welcomed the European Commission's publication of proposals for revised legislation concerning veterinary medicines and medicated feed earlier today.
The EC says the proposals are designed to increase the availability of veterinary medicines, reduce administrative burden, stimulate competitiveness and innovation, improve the functioning of the internal market and address the issue of antimicrobial resistance.
NOAH says that currently, the manufacturers of veterinary medicines struggle with a regulatory system with some serious flaws, including:
NOAH chief executive Phil Sketchley said: "NOAH will be looking at the detail of the texts in the coming days and weeks, and reviewing their potential impact. We look forward to working with the VMD, who have called stakeholder workshops to examine the texts. We will also be supporting our European federation IFAH-Europe as they work determinedly with the European institutions over the coming years to support the Commission's vision for a more efficient regulatory system for veterinary medicines in Europe.
"We believe the value our industry brings to society is very high, despite being quite a small sector. For example, veterinary medicines benefit public health by preventing zoonotic disease and supporting food security.
"With synergies with our own UK Government's commitment to reduce unnecessary red tape, which is a key theme for DEFRA, the animal health industry in Europe needs greater efficiency to cut the red tape for our industry. We look forward to a streamlined registration process which delivers a single European marketing authorisation for all veterinary medicines.
"We will also be considering if the text has any particular implications for the UK animal health market and access to medicines for our animals."
NOAH says it also welcomes the revised medicated feed legislation. Phil Sketchley said: "NOAH believes this is an important route for administering prescription medicines to animals. We will work to help ensure the legislation is capable of maintaining and strengthening this route."
A new long acting sheep injection has been launched by Fort Dodge Animal Health which the company says will offer significant benefits to sheep farmers for both internal and external parasite control.
Cydectin 2% LA for sheep is the latest product to join the Cydectin range and follows the long acting injection for cattle.
Based on Moxidectin, the product delivers a long action against worms, up to 111 days and scab, 60 days from a single injection.
Andrew Wylie from Fort Dodge said: "To put this into context, apart from the existing Cydectin range which lasts up to 35 days, no other product is licensed with persistent activity against worms and scab. Cydectin 2% LA for sheep offers three times the worm cover and double the scab cover from a single injection.
"Therefore farmers will benefit from Cydectin 2% LA through the combination of a single injection with extended persistency leading to a reduction in the number of treatments needed for worms and scab and the potential increase in lamb weight gain due to a lower worm and scab challenge."
Fort Dodge recommends the following three key uses for Cydectin 2% LA given the persistent effect and single shot:
Administration is by a single sub-cutaneous injection high up the neck at the base of the ear which is designed to limit the withhold period to 104 days. The technique is not difficult and, if used with the multidose applicator supplied, farmers will find it a straightforward procedure.
Cydectin 2% LA is available in 50ml, 200ml and 500ml bottles and with a dose rate of 1ml per 20kg, a 500ml pack will treat 200 sheep at 50kg. For further, call Fort Dodge on 01489 781711.
Genitrix has announced that HY-50 Vet®, a sodium hyaluronate treatment for equine joints, has now been authorised for intravenous (IV) use.
Available until now for intra-articular (IA) use only, the company says HY-50 delivers the highest concentration of sodium hyaluronate on the market for the treatment of non-infectious joint inflammation and the enhancement of joint function.
Genitrix also says that, as IV application requires less specialist preparation than IA, HY-50 is now a practical solution for mixed practices with a smaller equine case load. Injected intravenously, the product will also benefit horses with multiple joint injuries.
HY-50 is presented in a 3 ml pre-loaded syringe, delivering 50 mg of sodium hyaluronate. It costs £55.50.
Rob Watkins, Marketing Director of Genitrix, said: "The efficacy of sodium hyaluronate is well established and we're delighted to be able to offer the IV route of administration. We know it will meet a real need in the market for a lameness treatment which is proven and simple to administer."
"Perhaps most importantly, in these financially difficult times, the high concentration of the product makes it a cost-effective approach compared with competitive products. We believe it will offer an affordable treatment option for owners who are anxious to treat their horses but may be discouraged by the high cost of many treatments."
For further information, see http://www.genitrix.co.uk/ or ring 01403 786345.
Novartis Animal Health has announced that it is offering regular updates Schmallenberg virus, including the number and counties of affected farms, on its farm animal health website: www.farmanimalhealth.co.uk.
The new website is a resource for vets, SQPs and farmers and also contains background information on the virus, its symptoms and suggestions for control.
Helen Langham, Brand Manager at Novartis Animal Health, said: "There is still a lot that isn't known about the Schmallenberg virus, so it is essential that those involved in the animal health industry and livestock production are kept informed. Our website provides current information and links to relevant resources to help people stay up to date".
For more information go to www.farmanimalhealth.co.uk/latestdiseaseupdates
Protexin Veterinary has launched CystoPro, a new product to aid in the management of urinary tract infections in dogs.
According to the company, the key active ingredients in the new product are proanthocyanidins (Type A PACs), derived from cranberries, which work by reducing the ability of E.coli bacteria to infect a dog's urinary tract.
In addition, CystoPro contains the probiotic Enterococcus faecium (NCIMB 10415) E1707 which Protexin says reduces pathogenic bacteria within the gastrointestinal tract thereby lessening the risk of ascending UTIs of faecal origin.
The product also contains Mannan-oligosaccharide (MOS), which Protexin claims binds E.coli and upregulates the innate immune system by attracting phagocytes to opsonise the bacteria.
Lastly CystoPro contains N-acetyl D-glucosamine which is said to reinforce the structure of the Glycosaminoglycan (GAG) layer that lines and protects the bladder urothelium.
CystoPro is available in boxes of 30 and 120 capsules.
The RCVS is now accepting applications from veterinary surgeons and veterinary nurses who wish to serve as members of the RCVS Ethics Review Panel (ERP).
The ERP has been established by the RCVS in order to facilitate access to ethical review for those wishing to undertake practice-based research outside of a university or industry context. The ERP will begin considering research proposals from veterinary surgeons and veterinary nurses from 1 August 2016 and the trial will run for a period of one year. The process will be limited to considering research projects involving cats and/or dogs during the trial period, with the possibility of expanding to other species if the trial is extended or made permanent.
The trial came about following a joint working party established by the RCVS and British Veterinary Association which reported on ethical review and found that an increasing amount of clinical research was being conducted by vets based in private practice. One of the key recommendations of the report was that the RCVS should consider establishing a committee for ethical review of practice-based research.
Ahead of the launch of the ERP, the RCVS is currently looking to recruit four veterinary surgeon members and a veterinary nurse member to the Panel to join a lay member and ethicist Chair.
More details about the roles, the function of the ERP and how to apply can be found at www.rcvs.org.uk/workforus and www.rcvs.org.uk/ethics. Those who are interested in applying can also email ethics@rcvs.org.uk for an informal discussion. The closing date for applications is 15 April 2016.
The Registrar and Secretary of the Royal College of Veterinary Surgeons, Jane Hern, has announced that she will be standing down at the end of the year.
After 15 years in the job, Jane says she has been pleased to oversee a number of significant reforms and new initiatives in her time leading the organisation, but has decided that it is time to move on and pursue other interests.
The College says it is now embarking on a comprehensive review of its governance, committee and management structures, during which the Officers and Council will consider how best the executive should be led in future.
Jane said: "I have greatly enjoyed my time with the College and the Trust. Working with a profession held in such high regard by the public has been a real pleasure. I wish veterinary surgeons, veterinary nurses and all my colleagues all the very best for the future."
The President, Dr Jerry Davies said: "The Royal College has been very fortunate in having the benefit of Jane's wisdom and guidance for so many years, and we wish her every success in the future."
Pfizer Animal Health has launched a new range of diabetes support materials, including a DVD, post-prescription leaflet and home recording chart for owners of diabetic cats and dogs; a vet detailer, poster and blood glucose monitoring chart for the practice.
The company says that diabetes is on the increase in pets, as the level of obesity in cats and dogs escalates. Current estimates put the disease prevalence at 0.32% in the dog population1 with similar levels suggested for cats with some being as high as 1 in 1002. With increasing economic pressures and busy lifestyles, many owners are reluctant to take on the challenge of a diabetic pet, yet most pets respond extremely well to treatment.
Susan Mitchell, Insuvet® Product Manager at Pfizer Animal Health, believes that communication is key: "Helping owners to understand that treatment need not be difficult and that routines can be flexible enough to fit in with their lifestyles is critical. Time and time again it has been shown that cost is not always the primary consideration when it comes to treating the pet that is viewed as a much loved member of the family.
"Ensuring that owners understand exactly what will be expected of them is likely to be pivotal to the success of diabetes management than might first be assumed. Our new range of support material focuses on that need and takes the owner right the way through the process, from that initial diagnosis when decisions hang in the balance, to improving compliance by providing all the tools necessary for effective day to day management of the disease."
The new support materials include a DVD that explains all that clients need to know about the condition. This, says Pfizer, is the ideal choice after initial diagnosis, to reinforce and support the dialogue that takes place in the clinic environment. Shock, fear and confusion may mean that many owners will simply fail to take in all that their vet has to tell them after the initial diagnosis. This, in turn may prevent the owner from making an objective decision about their pet's future.
Once emotions have settled the client can watch the DVD in their own home, start to approach the future more rationally and decide what adaptations may have to be made. A post prescription leaflet is available to provide reassurance about the daily routine of monitoring a diabetic pet and a home recording chart to aid long-term compliance.
Of course, diabetic patients can be just as challenging in the practice environment so a comprehensive vet detailer is available along with blood glucose monitoring charts, a poster detailing what to do in a keto-acidotic emergency, a veterinary nurse discharging list and a clinic letter.
For further information on the Insuvet® range or to request support materials for diabetic clinics or individual patients, vets and nurses should contact their Pfizer Business Account Manager. For any technical questions about the Insuvet range call the Pfizer Animal Health Technical Support Line on 0845 3008034.
Forum Animal Health is launching a new programme designed for transition cows to help avoid milk fever relapses: the Milk Fever Pack.
According to the company, the new Milk Fever Pack provides a continuous and complete supply of readily available oral calcium to avoid relapses which also gives the cow extra support until her system is back in control. Unlike intravenous calcium, oral calcium will not suppress parathyroid hormone (PTH) release and therefore will not turn off the cow's natural mechanism to regulate blood calcium levels.
Each pack contains one sachet of Agger's® Fresh Cow which supplies essential calcium, energy and rehydrates the cow; and two tubes of Botonic® Calcium which create a mild metabolic acidosis to enable the cow to mobilise calcium efficiently.
Forum Animal Health says the new Milk Fever Pack has been developed in close collaboration with a leading veterinary nutritionist to allow veterinary surgeons to be involved at an earlier stage. The veterinary surgeon can then leave a follow-up protocol for the client to use, helping to avoid milk fever relapses. It gives veterinary surgeons a chance to introduce standard operating procedures into herd health plans bringing better control of milk fever on farms.
For more information, please contact Forum Animal Health on 01737 781416 or animal.health@forumgroup.co.uk.
The Kennel Club has broadly welcomed Professor Sir Patrick Bateson's 'Independent Inquiry into Dog Breeding', which has recommended that steps be taken to tackle irresponsible breeders and to change the way the public think about buying dogs.
The Kennel Club, which commissioned and funded the report in conjunction with Dogs Trust, welcomes the report's focus on irresponsible breeders who farm puppies with little concern for their welfare and those who sell poorly socialised puppies on to owners to use as 'status dogs' or as fighting weapons.
The Kennel Club agrees that additional training and support needs to be given to local authorities, which are responsible for issuing breeding licences to those people who breed five or more litters of puppies in a single year, as the current provisions are deemed to be ineffective. It agrees that compulsory microchipping of dogs and increased public education to stop people falling prey to puppy farmers and to help them find responsible breeders are necessary.
It is also glad that the report recognises the need for a 'robustly policed and well respected quality assurance scheme', consisting of breeders that buyers can trust to look after their puppies' health and welfare, and that it suggests that the Kennel Club's Accredited Breeder Scheme, with some modification could be used.
However, the Kennel Club is concerned that the report could have gone further and that its recommendations do not appear directly to cover those breeders who breed less than five litters per year and who are not part of the Kennel Club Accredited Breeder Scheme. The Kennel Club would have liked to have seen a recommendation for regulation to ensure that these breeders follow higher standards, such as compulsory health testing.
Caroline Kisko, Kennel Club spokesperson, said: "Whilst the report recognises that the majority of breeders are responsible, there are those whose actions are bringing the rest of the dog breeding community into disrepute and this needs to be stopped.
"We are glad that the report recognises that the Kennel Club has made a good start in its efforts to unite responsible breeders within its Accredited Breeder Scheme, for the benefit of puppies and puppy buyers, and we believe that this should be the basis for moving forward. We are currently working towards UKAS accreditation of the scheme as suggested by Professor Bateson.
"We agree that responsible breeders should be rewarded and believe that the show ring is the best forum for this. The report recognises that 'dog showing and judging are a powerful lever for change' and the Kennel Club is dedicated to ensuring that only the healthiest dogs are rewarded at shows.
"Public education is vital and all dog welfare organisations must continue to work together to ensure that people know what to look for when buying a dog."
The report looks at genetic diversity in breeds and recognises that the Kennel Club has banned close matings. It advises that future decisions about matings that could affect genetic diversity should be 'breed specific' and made upon evidence based scientific information and advice. To this end it is recommended that the veterinary profession should gather data to show the prevalence of certain diseases and that an advisory council should develop evidence based breeding strategies.
Mrs Kisko continued: "The Kennel Club has long recognised that genetic diversity plays a crucial role in safeguarding the health of dogs and the report is absolutely right to suggest that there are no further blanket rules in place but that decisions are based upon scientific knowledge and are made on a breed by breed basis. This is why we are well on the way to creating a new database which will revolutionise the way that we record dog health data. The data will enable us to bring out our Mate Select programme, which will help breeders to find suitable mating pairs which are most likely to produce healthy offspring. The database will go further than the report's recommendation, as the data will be attributable to specific dogs, rather than being anonymous, and will give us a better picture of the health of pedigrees and crossbreeds. Such knowledge is critical and will enable us to provide information to breeders, vets, geneticists and ultimately the puppy buyer.
"We are keen to harness as much knowledge as possible for the benefit of dogs so we welcome the principle of an advisory council whose members will work with the Kennel Club to advise on decisions about breeding and health. A structure already exists in the form of the Kennel Club's Dog Health Group with its recently extended remit. Additional independent experts include canine and human geneticists, veterinary surgeons and an epidemiologist. Using this framework for establishing the advisory council under an independent chairman would save significant sums of money, which can instead be devoted entirely to the dog health research that the report identified as being in 'urgent' need of more funding."
The Kennel Club and Dogs Trust will now arrange a meeting between all relevant parties in order to move forward with the recommendations from all three reports.
The full report may be downloaded at www.dogbreedinginquiry.com
Cat Professional is carrying out a survey to assess the use of Zylkène in cats with idiopathic cystitis (FIC), and is looking for owners whose cats are using the treatment to complete an online survey.
Zylkène is a nutritional supplement which has been reported to have positive effects in managing stress in cats and dogs. Zylkène is commonly used for reduction of stress in cats with FIC.
Veterinary practices that agree to help Cat Professional recruit clients whose FIC cats are receiving Zylkène will receive:
On completion of the survey, participants will receive a free electronic copy of the book 'Caring for a cat with lower urinary tract disease'.
For more information on the study, please visit our website: http://www.catprofessional.com.
The survey is accessible from the home page or directly at http://www.catprofessional.com/urinary-survey.html
Norbrook has announced the launch of Total Pet Health Month 2012, a pet education campaign aimed at improving the health and welfare of dog and cats.
The campaign, which began on 13th August, offers advice and guidance to pet owners about a range of pet health problems. Norbrook says the main aim is to encourage owners to speak with their vet if they have any concerns about their pet.
The main vehicle for the campaign is the Norbrook's Pet Healthcare website on http://www.norbrook.com/pets-health/.
The first topic featured in Total Pet Health Month 2012 is parasite control and treatment. Norbrook commissioned petbuzz to carry out research on parasite concerns for pet owners.
Michelle Jones, Norbrook Small Animal Brand Manager said: "Almost 80% of pet owners reported seeing an increase in fleas and ticks in the summer so it is timely to launch Total Pet Health Month with a focus on parasite control. 70% of respondents were concerned about the risk of skin problems and discomfort in their pets due to fleas and ticks. We hope that our campaign will address these concerns and help pet owners manage what can be a very unpleasant and irritating problem."
The research highlighted that 63% of pet owners sought advice from a vet in relation to flea and tick treatment and 66% purchased treatments from a veterinary practice.
Michelle said: "It is very encouraging that two thirds of pet owners purchase treatments from a vet. Total Pet Health Month is a great opportunity for pet owners to find out more about concerns they have for their pets. We would actively encourage them to engage with animal health experts and veterinarians because they will get invaluable advice during the purchase which they may not otherwise get."
During Total Pet Health Month 2012, Norbrook will also look at conditions including gum disease and hip dysplasia.
Total Pet Health Month will run across the Total Pet Publishing network (a Europe-wide network of pet sites). Norbrook says it will engage with more than 3m pet owners, guiding them to the Norbrook pet healthcare portal and to seek solutions and treatments from their veterinary practice.
The petbuzz market research was conducted in May 2012 with 1,147 pet owners: 86% dog owners, 41% cat owners, 10% rabbit owners.
Dechra has launched a new support package to help veterinary surgeons and nurses dealing with otitis externa, and to encourage compliance amongst owners whose dogs are being treated for the disease.
Called the Dermatology Partners in Practice programme, the initiative includes a client compliance pack which contains the Guide to Good Ear Care, a leaflet on handling techniques, a treatment diary and a consultation report.
Roger Brown, Senior Brand Manager at Dechra Veterinary Products, said: "We are committed to supporting vets and vet nurses as they deal with cases of otitis externa at a time when responsible use of antimicrobials is in the spotlight.
"It is essential that owners comply with treatment programmes and that vets are supported with involving owners, which can lead to better outcomes for dogs receiving treatment and can be good for developing the practice business as well.
"We know from our research, and from talking to the vets and vet nurses, that owner compliance can be a barrier to successful first-time management and resolution of otitis externa.
"The new Client Compliance Pack is designed to support veterinary professionals as they diagnose, control and maintain this complex condition."
"All in all, it will provide extra support to the owner as they carry through the professional treatment plan once back home."
Veterinary surgeons are being invited to arrange a Business Support Discussion to find out more about the Dermatology Partners in Practice Programme and how it can benefit their practice. For details and to know more about the pack, call 01939 211215 or visit dechra.co.uk/timetochange.
The survey, believed to be the first of its type, is being conducted by MRes student Mark Turner MRCVS (pictured above right), under the direction of Martin Whiting and Elizabeth Armitage-Chan. It's based on a tool used in the human health care sector to monitor care quality in hospitals and G.P surgeries.
All veterinary surgeons, veterinary nurses and practice managers in small animal practice are invited to complete the survey, which is confidential and has received research ethics approval from the RVC.
Mark said: "We believe this survey could represent a significant milestone in the profession's understanding of patient safety. This topic is still in its infancy in our industry, but there is already evidence to suggest we lag some way behind the NHS in our application of important safety principles such as openness and 'learning'.
Without this sort of safety culture, the profession risks missing important opportunities to improve quality and safety for the animals in it's care. One of the questions we would like to answer is: 'When mistakes occur in practice, are lessons routinely being learnt to prevent the same thing from happening again?'
He added: "In the NHS this subject has received a lot of media coverage after stories like the Bristol heart scandal and the enquiry into Mid Staffs Hospital. And our health system now understands that patient safety relies on a whole organisation effort to maintain standards. What we don't know however is how well we are doing in this regard."
Please do take take some time to complete the survey, and SHARE this story with your colleagues (buttons below). It's an important piece of work that should really benefit the profession. You can also discuss the project with Mark here.
https://www.surveymonkey.co.uk/r/VetPatientSafety
Genitrix has launched a new Essential Fatty Acids (EFA)-based treatment to aid the management of skin conditions in cats and dogs. Called Omegaderm+, and offered in an airless pump applicator for mess-free use, it helps to soothe irritated skin and can be used for the long term maintenance of normal skin in pets prone to allergic skin conditions, such as flea allergy dermatitis, atopy and food allergy. It can also be used as a supplement to help prevent shedding, scratching, dull coat and dry flaky skin in cats. Omegaderm+ has been formulated to be highly palatable to ensure easy dosing by pet owners, an important consideration when client compliance with long term therapy is required. Both products are rich in salmon, sardine and anchovy oil and, in tests, Omegaderm+ Dog offered without food was accepted by 69% of dogs while the majority of cats preferred food with Omegaderm+ on it than the food alone.* Commenting on the launch of Omegaderm+, Howard Wilder, Managing Director of Genitrix, said: “The value of EFAs in managing skin conditions in cats and dogs is widely recognised but they are a supplemental requirement in dogs and cats due to the inability of mammals to synthesize them.
Research carried out by the Kennel Club to coincide with the start of Open for Dogs Week has found that 40% of British people think dogs are a happy alternative to having children.
One reason for this is perhaps because 25% of respondents said that a dog would fit more easily with their lifestyle than a child. Or maybe it's partly because 25% said that whilst their children always come first, they prefer to do things with their dog.
In addition, 80% said their dog is attentive and loving when out and about, compared to only 50% who said the same is true of their other half.
However, despite the central place that dogs hold in their owners' hearts, the Kennel Club says many people experience difficulty taking their dogs out and about, particularly to restaurants. In the survey, 40% said that they have problems finding a place where their dog is welcome while they eat, and almost 50% said that they'd like to see a wider variety of restaurants open their doors to dogs.
Caroline Kisko, Kennel Club Secretary, said: "This research proves what a well loved member of the family a dog is. Given how much we love spending time with our dogs, it is surprising that there are still so many businesses that refuse to allow dogs in their premises, but there is a real appetite for this to change.
"The Kennel Club's Open for Dogs website lists more than 26,000 places throughout the UK and Europe that allow dogs inside, which makes it easier for dog owners to plan days out and holidays without having to leave their dogs behind.
"During Open for Dogs Week we are asking businesses, whether it is a restaurant, hotel, pub, shop or office, to trial a dog friendly policy. There are more than eight million dogs in the UK, so those that get involved will be appealing to a massive customer base, which can only be a good thing in tough economic times." The Kennel Club's Open for Dogs Week runs from 20-26 August 2012 and businesses and public places are encouraged to adopt a dog friendly policy for well behaved dogs.
To nominate your favourite dog friendly venue or town for the Kennel Club's Open for Dogs Awards, visit www.openfordogs.org.uk. The deadline for nominations is 31st August.
The British Equine Veterinary Association (BEVA) has issued guidelines to help vets employ overseas veterinary graduates successfully.
BEVA says that whilst employers should not discriminate based on nationality, language or place of graduation, it believes they have a duty to ensure all employees have the required level of linguistic and clinical skills to enable them to undertake their role safely and effectively.
The advice explains how to interpret English Language Qualification test results, highlights European Veterinary Schools that have not been approved by European Association of Establishments of Veterinary Education (EAEVE) and reminds employers that compulsory Extra Mural Studies (EMS) is unique to veterinary schools in the UK and Ireland.
Each year many foreign veterinary graduates register to work in the UK. By providing this advice BEVA hopes that employers will find it easier to navigate the differences between graduates from various veterinary schools across Europe, to uphold the reputation of the profession.
Mark Bowen, President Elect of BEVA, said: "At a time when politicians are debating language skills amongst medical graduates, it is useful to remind employers of the complex language skills required to provide the public with the service they expect. This guidance should assist employers in identifying the skilled workforce they need, while navigating the complexities of different English Language Qualifications and different veterinary qualifications."
Tim Greet, former BEVA President and a candidate for RCVS Council, said: "Whilst not condoning any discrimination based upon nationality, it seems only common sense to make sure that a new employee, from whatever background, can cope with the necessary level of communication, so fundamental in modern veterinary practice. A certain level of practical skill should also be expected to avoid compromise to patient welfare and to underpin continued professional development."
The Veterinary Schools Council is supportive of the guidelines. A spokesperson for the Council said: "It is a valuable document that should be helpful to any employer who is considering recruitment of a veterinarian from the EU."
For further information and to download a copy of the document visit www.beva.org.uk
The BVA and the RCVS are inviting applications from veterinary surgeons to join the new Vet Futures Action Group, set up to drive forward the ambitions identified in the Vet Futures report launched at BVA Congress at the London Vet Show on 20 November.
The Vet Futures report, Taking charge of our future: A vision for the veterinary profession for 2030, was the culmination of a year-long joint project by BVA and RCVS designed to help the veterinary profession prepare for, and shape, its own future. The Action Group is a vital next step in the Vet Futures project, ensuring the delivery of the report’s six ambitions and 34 recommendations.
BVA and RCVS are seeking seven veterinary surgeons and one veterinary nurse to join the Action Group to ensure there is buy-in from across the professions and to drive forward workstreams of activity. The group will be co-chaired by the BVA and RCVS Presidents, and both Junior Vice-Presidents will sit on the group. Action Group members will be independent and will not represent, or be required to report back to, any particular organisation.
Veterinary surgeons or nurses keen to apply for an Action Group role should have experience of working as an active member of a group or committee and the ability to deliver, engage and inspire others. The veterinary surgeon members should have specific expertise, knowledge and experience in relation to at least one of the Vet Futures ambitions or the cross-cutting issue of veterinary education. The ambitions cover:
Successful applicants must be able to attend three all-day meetings in London (9 February, 17 March and 12 May) and an all-day Vet Futures Summit (20 June), with a time commitment totalling approximately seven days between February and June 2016. The group will be supported by BVA and RCVS staff. For the full Vet Futures Action Group role profile and terms of reference, please visit: www.vetfutures.org.uk.
The deadline for applications is 12 noon, 31 December 2015.
Across Europe, the company has over 30 technical experts who get over 2,500 technical calls each year about Cushing’s.
The company also publishes the Dechra Academy, which provides a range of free online courses for vets.
There's also Dechra’s endocrinology app which was developed using data from the Royal Veterinary College’s VetCompass database to help vets diagnose and manage the endocrine disorders Addison’s disease (hypoadrenocorticism) and Cushing’s syndrome.
For owners, Dechra publishes the 'Suspecting Cushing’s' website and has created the Cushing’s monitoring app to help simplify the management process, improve compliance with medication and increase engagement in the dog’s care.
Sarah Musgrave, companion animal brand manager at Dechra, said: “Dechra has extensive experience in endocrinology.
"Cushing’s can be a challenge to identify, diagnose and manage and our ‘They’ve got Cushing’s. You’ve got us’ initiative demonstrates the comprehensive support that we have available for both vets and dog owners to help ensure that dogs with Cushing’s live long and healthy lives.”
https://www.dechra.co.uk/cushings-connect
Defra has announced the detection of Bluetongue (Serotype 1) (BTV1) in five imported cattle on a premises near Blackpool in Lancashire.
The animals originated from within the BTV1 and 8 Restricted Zone in the south west of France and were detected as a result of post-import testing carried out by Defra on all Bluetongue susceptible animals arriving from continental Europe. The animals' documentation complied with the EU Bluetongue rules governing the movement of livestock as the movement occurred at least 60 days after they had been vaccinated.
This is the first case of BTV1 infection in the UK and the five animals have been culled as they may pose a disease threat to other animals. One further animal from the same consignment has also been culled. Test results for that animal were positive for bluetongue although it was not possible to determine the serotype.
There is no evidence that BTV1 is circulating in the UK and no additional control zones have been declared.
This response is in accordance with Defra's Bluetongue Control Strategy. The premises are now under restriction while an epidemiological investigation takes place. This will include further checks on the other animals present on the premises.
Chief Veterinary Officer Nigel Gibbens said: "This is the first case of BTV1 infected animals being imported into the UK. Taking into account the epidemiological evidence and the consideration of the risk represented to British livestock, I have taken the decision to cull these animals.
"This incident shows how important it is for farmers to consider potential disease risks when buying stock. Buyers need to consider how best to protect their own businesses and those of their neighbours and make sure they are clear about the stock they are intending to buy."
Defra continues to test all susceptible animals imported to the UK from continental Europe for all strains of Bluetongue and continues to urge industry to consider the risks and check the health and vaccination status of animals when sourcing any animals from within the UK or abroad.
In line with EU legislation, and our UK Control Strategy agreed with industry, control measures are in place in UK and abroad to prevent the spread of Bluetongue from existing zones around Europe:
Vetoquinol is offering vets the opportunity to win one of five Selekt Cattle Pumps worth £240. In order to take part, you'll need to tell Vetoquinol about your experiences with Marbocyl 10% when treating acute mastitis.
Susan Mitchell, Vetoquinol's Large Animal Product Manager said: "This case study competition aims to gather information on the incidence and treatment of acute mastitis. Acute mastitis is a genuine veterinary emergency and rapid treatment is vitally important."
Vetoquinol says Marbocyl 10% has proven to be an effective treatment for acute E.coli mastitis, with a bactericidal action which does not liberate endotoxins. Administered intravenously, Marboyl 10% provides rapid improvement and an early return to milk production.
The company also says farmers have found toxaemic mastitis cases have benefited from the use of fluid therapy, using the Selekt Cattle Pump. Oral fluid therapy is a quick, easy and inexpensive option to intravenous treatment and improves the efficacy of hypertonic saline.
To enter the competition, visit http://www.vetoquinol.co.uk/, click the Marbocyl link on the right, and download and complete a brief case history.
Five winners will be chosen at random on 30th June 2010.
Woodley Veterinary Equipment has launched a range of eight veterinary stains.
The company says that the range offers a comprehensive product base to suit most requirements, and that they are all quick and easy to use.
The range is made up of the following individual stains for single test use:
Also available is the Automated Slide Stainer, which Woodley says is capable of precise, balanced slide stains for use with Haematology and Gram staining. Maintenance free and self-cleaning the Automated Slide Stainer is also programmable for individual preferences.
For more information, email: sales@woodleyequipment.com or call Woodley's customer service team on +44 (0) 1204 669033 Option 1. Alternatively visit www.woodleyequipment.com
New research published in Epidemiology and Infection (Cambridge University Press) reveals that direct contact between badgers and cattle is rare, suggesting that it may be rare for bovine tuberculosis (TB) to be passed on through the two species meeting each other on pasture.
For the research, which was conducted by the Royal Veterinary College and the Food and Environment Research Agency, researchers investigated direct and indirect interactions between badgers and cattle by fitting automated high-tech proximity loggers to animals and placing base stations at badger latrines located on pasture, in an area of south-west England with a high-density badger population, over a period of 12-months.
Direct interactions (within 1.4 metres) between badgers and cows at pasture were very rare, with only four out of over 500,000 animal-to-animal contacts recorded between the two species.
Indirect interactions (visits to badger latrines) were far more frequent than direct contacts, with 400 visits by badgers and 1700 visits by cattle recorded. This suggests that indirect contacts might be more important than direct in terms of disease transmission at pasture.
During the study half of the badgers tested positive for TB, however the infection status of individual badgers did not affect the frequency or duration of their visits to latrines located on pasture grazed by cattle.
Bovine tuberculosis caused by infection with Mycobacterium bovis is endemic in cattle in parts of England and Wales and its control is hindered by the presence of infection in the European badger. While M. bovis is clearly transmitted between cattle and badgers, it is has not previously been known where, when or how often transmission occurs.
Dr Julian Drewe from the Royal Veterinary College who led the study, said: "Our findings reveal that direct contacts between badgers and cattle at pasture are surprisingly rare, despite ample opportunity for interactions to occur, suggesting that the two species may be ignoring or even actively avoiding one another. The study was conducted in an area with a high badger population, so it is likely that such direct contact will be even less frequent in areas of the country where there are fewer badgers.
"Indirect visits by both species to badger latrines were significantly more common than direct contacts between badgers and cattle, which suggests that these represent the more typical nature of interspecies contact. Future research aiming to quantify TB risk to cattle from badgers might be best to focus on indirect contacts occurring at latrines and on contacts occurring away from pasture, for example in farm buildings.
"This clearly has disease management implications, and more work is now needed in this area to look at how such contact can be limited, to reduce the number of cases of bovine TB in the future."